BMS offloads U.S. distribution to Exel

Third-party logistics provider Exel will provide U.S. distribution for Bristol-Myers Squibb. To get the deal rolling, the drug giant has sold distribution centers in Mount Vernon, IN, to the service provider, a unit of DHL.

BMS is turning over logistics and finished-goods distribution responsibilities for cold and non-cold chain products, clinical trials, samples and exports. The deal also involves a second distribution facility that Exel will open and manage in Pennsylvania.

BMS isn't the only big pharma to offload logistics. Pfizer turned over distribution operations and a facility to Exel late last year in an outsourcing arrangement.

- see the Exel announcement

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.